scholarly journals Vaniprevir plus peginterferon alfa‐2b and ribavirin in treatment‐experienced Japanese patients with hepatitis C virus genotype 1 (GT1b) infection: Phase 3 studies

2016 ◽  
Vol 31 (10) ◽  
pp. 1674-1683 ◽  
Author(s):  
Hiromitsu Kumada ◽  
Satoshi Mochida ◽  
Fumitaka Suzuki ◽  
Kazuaki Chayama ◽  
Yoshiyasu Karino ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Japanese Patients ◽  
Genotype 1 ◽  
Virus Genotype ◽  
Phase 3 ◽  
Peginterferon Alfa

scholarly journals Vaniprevir plus peginterferon alfa-2b and ribavirin in treatment-naive Japanese patients with hepatitis C virus genotype 1 infection: a randomized phase III study

2015 ◽  
Vol 51 (4) ◽  
pp. 390-403 ◽  
Author(s):  
Norio Hayashi ◽  
Makoto Nakamuta ◽  
Tetsuo Takehara ◽  
Hiromitsu Kumada ◽  
Akiko Takase ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Japanese Patients ◽  
Phase Iii ◽  
Genotype 1 ◽  
Virus Genotype ◽  
Treatment Naïve ◽  
Phase Iii Study ◽  
Peginterferon Alfa

scholarly journals Simeprevir plus sofosbuvir (12 and 8 weeks) in hepatitis C virus genotype 1-infected patients without cirrhosis: OPTIMIST-1, a phase 3, randomized study

Hepatology ◽  
2016 ◽  
Vol 64 (2) ◽  
pp. 370-380 ◽  
Author(s):  
Paul Kwo ◽  
Norman Gitlin ◽  
Ronald Nahass ◽  
David Bernstein ◽  
Kyle Etzkorn ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Randomized Study ◽  
Genotype 1 ◽  
Virus Genotype ◽  
Phase 3

235 SAPPHIRE II: Phase 3 Placebo-Controlled Study of Interferon-Free, 12-Week Regimen of ABT-450/r/ABT-267, ABT-333, and Ribavirin in 394 Treatment-Experienced Adults With Hepatitis C Virus Genotype 1

2014 ◽  
Vol 146 (5) ◽  
pp. S-904
Author(s):  
Ira M. Jacobson ◽  
Stefan Zeuzem ◽  
Tolga Baykal ◽  
Rui T. Marinho ◽  
Fred Poordad ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Controlled Study ◽  
Genotype 1 ◽  
Virus Genotype ◽  
Phase 3

scholarly journals Simeprevir plus sofosbuvir in patients with chronic hepatitis C virus genotype 1 infection and cirrhosis: A phase 3 study (OPTIMIST-2)

Hepatology ◽  
2016 ◽  
Vol 64 (2) ◽  
pp. 360-369 ◽  
Author(s):  
Eric Lawitz ◽  
Gary Matusow ◽  
Edwin DeJesus ◽  
Eric M. Yoshida ◽  
Franco Felizarta ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Genotype 1 ◽  
Virus Genotype ◽  
Phase 3 ◽  
Chronic Hepatitis C Virus

Impact of Ribavirin Dose Reductions in Hepatitis C Virus Genotype 1 Patients Completing Peginterferon Alfa-2a/Ribavirin Treatment

2007 ◽  
Vol 5 (1) ◽  
pp. 124-129 ◽  
Author(s):  
K. Rajender Reddy ◽  
Mitchell L. Shiffman ◽  
Timothy R. Morgan ◽  
Stefan Zeuzem ◽  
Stephanos Hadziyannis ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Genotype 1 ◽  
Virus Genotype ◽  
Peginterferon Alfa ◽  
Dose Reductions

scholarly journals Randomized trial of peginterferon alfa-2b and ribavirin for 48 or 72 weeks in patients with hepatitis C virus genotype 1 and slow virologic response

Hepatology ◽  
2010 ◽  
Vol 52 (4) ◽  
pp. 1201-1207 ◽  
Author(s):  
Maria Buti ◽  
Yoav Lurie ◽  
Natalia G. Zakharova ◽  
Natalia P. Blokhina ◽  
Andrzej Horban ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Randomized Trial ◽  
Virologic Response ◽  
Genotype 1 ◽  
Virus Genotype ◽  
Peginterferon Alfa
Sign in / Sign up

Export Citation Format

Share Document